Geron reported $248.71M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Amgen USD 9.62B 2.19B Sep/2025
Bio Techne USD 2.01B 45.18M Dec/2025
Cassava Sciences USD 81.57M 6.4M Sep/2025
Cytokinetics USD -521.12M 216.32M Sep/2025
Exelixis USD 2.16B 127.16M Sep/2025
Genmab DKK 5.3B 6M Jun/2025
Geron USD 248.71M 10.82M Sep/2025
Gilead Sciences USD 21.46B 1.78B Sep/2025
Incyte USD 4.65B 480.29M Sep/2025
MacroGenics USD 67M 20.38M Sep/2025
Novartis USD 44.75B 2.7B Sep/2025